Search research articles
Contact Us
Filters
Showing results (71-80 of 88) with videos related to
Page
of 9
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
April 24, 2020
Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34)
Christian F Singer, Georg Pfeiler, Michael Hubalek, et al.
Lancet (London, England)
|
June 5, 2015
Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial
Michael Gnant, Georg Pfeiler, Peter C Dubsky, et al.
Breast Cancer Research and Treatment
|
June 5, 2017
First international consensus conference on standardization of oncoplastic breast conserving surgery
Walter P Weber, Savas D Soysal, Mahmoud El-Tamer, et al.
British Journal of Cancer
|
March 25, 2021
Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34
Rupert Bartsch, Christian F Singer, Georg Pfeiler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2011
A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors
Martin Filipits, Margaretha Rudas, Raimund Jakesz, et al.
NEJM Evidence
|
February 6, 2024
Long-Term Outcomes of Adjuvant Denosumab in Breast Cancer
Michael Gnant, Sophie Frantal, Georg Pfeiler, et al.
The New England Journal of Medicine
|
July 28, 2021
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer
Michael Gnant, Florian Fitzal, Gabriel Rinnerthaler, et al.
Annals of Surgical Oncology
|
October 31, 2023
Impact of Imaging-Guided Localization on Performance of Tailored Axillary Surgery in Patients with Clinically Node-Positive Breast Cancer: Prospective Cohort Study Within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Walter P Weber, Martin Heidinger, Stefanie Hayoz, et al.
Annals of Surgical Oncology
|
October 14, 2021
Retrospective, Multicenter Analysis Comparing Conventional with Oncoplastic Breast Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study
Florian Fitzal, Michael Bolliger, Daniela Dunkler, et al.
BMJ Open
|
September 3, 2021
Prepectoral versus subpectoral implant-based breast reconstruction after skin-sparing mastectomy or nipple-sparing mastectomy (OPBC-02/ PREPEC): a pragmatic, multicentre, randomised, superiority trial
Elisabeth A Kappos, Alexandra Schulz, Meredith M Regan, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 88) with videos related to
Sort By:
Page
of 9
European Journal of Cancer (Oxford, England : 1990)
|
April 24, 2020
Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34)
Christian F Singer, Georg Pfeiler, Michael Hubalek, et al.
Lancet (London, England)
|
June 5, 2015
Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial
Michael Gnant, Georg Pfeiler, Peter C Dubsky, et al.
Breast Cancer Research and Treatment
|
June 5, 2017
First international consensus conference on standardization of oncoplastic breast conserving surgery
Walter P Weber, Savas D Soysal, Mahmoud El-Tamer, et al.
British Journal of Cancer
|
March 25, 2021
Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34
Rupert Bartsch, Christian F Singer, Georg Pfeiler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2011
A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors
Martin Filipits, Margaretha Rudas, Raimund Jakesz, et al.
NEJM Evidence
|
February 6, 2024
Long-Term Outcomes of Adjuvant Denosumab in Breast Cancer
Michael Gnant, Sophie Frantal, Georg Pfeiler, et al.
The New England Journal of Medicine
|
July 28, 2021
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer
Michael Gnant, Florian Fitzal, Gabriel Rinnerthaler, et al.
Annals of Surgical Oncology
|
October 31, 2023
Impact of Imaging-Guided Localization on Performance of Tailored Axillary Surgery in Patients with Clinically Node-Positive Breast Cancer: Prospective Cohort Study Within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Walter P Weber, Martin Heidinger, Stefanie Hayoz, et al.
Annals of Surgical Oncology
|
October 14, 2021
Retrospective, Multicenter Analysis Comparing Conventional with Oncoplastic Breast Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study
Florian Fitzal, Michael Bolliger, Daniela Dunkler, et al.
BMJ Open
|
September 3, 2021
Prepectoral versus subpectoral implant-based breast reconstruction after skin-sparing mastectomy or nipple-sparing mastectomy (OPBC-02/ PREPEC): a pragmatic, multicentre, randomised, superiority trial
Elisabeth A Kappos, Alexandra Schulz, Meredith M Regan, et al.
Page
of 9